Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-01-10
2009-12-22
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C554S117000, C554S118000, C554S119000, C560S008000, C560S055000, C514S506000, C514S785000
Reexamination Certificate
active
07635716
ABSTRACT:
Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
REFERENCES:
patent: 3980700 (1976-09-01), Miyano et al.
patent: 4119727 (1978-10-01), Buendia et al.
patent: 6426359 (2002-07-01), Cameron et al.
patent: 6437146 (2002-08-01), Hattori et al.
patent: 6710072 (2004-03-01), Burk et al.
patent: 7323591 (2008-01-01), Old et al.
patent: 7405240 (2008-07-01), Old et al.
patent: 7429669 (2008-09-01), Old et al.
patent: 2001-163779 (2001-06-01), None
patent: WO 98/27976 (1998-07-01), None
patent: WO 98/58911 (1998-12-01), None
patent: WO 03/074483 (2003-09-01), None
patent: WO 2004-089411 (2004-10-01), None
Stella, Valentino J, Expert Opinion of Therapeutic Patents, Prodrugs as therapeutics, 2004 14(3): 277-280.
Wolff et al. (Burger's Medicinal Chemistry, 5th Ed., vol. 1, pp. 975-977, 1994).
Testa, Bernard, Biochemical Pharmacology, Prodrug Research: futile or fertile? 68 (2004) 2097-2106.
Ettmayer, Peter, Medicinal Chemistry, Lessons Learned from Marketed and Investigational Prodrugs, 47(10) (2004) 2394-2404.
Kwon, Younggil. Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists . Jun. 24, 2001. p. 213, paragraph 3.
“Metabolomics.” Retrieved online via the Internet [Jun. 17, 2008] URL: www.en.wikipedia.org/wiki/Metabolomics.
Patani, George A. Bioisosterism: A rational approach in drug design. Chem. Rev. 96 (1996) 3147-3176.
Baxter, Anthony D., et al.,Synthesis and Use of 7-Substituted Norbornadienes for the Preparation of Prostglandins and Prostanoids, 1986, 889, J. Chem. Soc. Perkin.
Dragoli, Dean R., et al.,Parallel Synthesis of Prostaglandin E1Analogues, 1999, 534-539, J. Comb. Chem.
Gac Todd S.
Ngo Vinh X.
Old David W.
Allergan Inc.
Allergan, Inc.
Forrestal Kevin J.
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
Substituted cyclopentanes or cyclopentanones as therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclopentanes or cyclopentanones as therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclopentanes or cyclopentanones as therapeutic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4087258